<DOC>
	<DOCNO>NCT01131078</DOCNO>
	<brief_summary>A study Avastin ( bevacizumab ) combination chemotherapy patient metastatic cancer colon rectum . The anticipated time study treatment disease progression .</brief_summary>
	<brief_title>A Study Avastin ( Bevacizumab ) Combination Chemotherapy Patients With Metastatic Cancer Colon Rectum</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Camptothecin</mesh_term>
	<criteria>adult patient &gt; =18 year age ; colon rectal cancer , metastases ; &gt; =1 measurable lesion . previous systemic treatment advanced disease ; radiotherapy site within 4 week study ; daily aspirin ( &gt; 325 mg/day ) , anticoagulant , medication know predispose gastrointestinal ulceration ; coexist malignancy malignancy diagnose within last 5 year ( except basal cell cancer cervical cancer situ ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>